Clinical Trial Update: Lamivudine and Adefovir to Treat Chronic Hepatitis B [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lamivudine and adefovir for chronic hepatitis B has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Adefovir dipivoxil (Hepsera) (adefovir dipivoxil)
• Lamivudine (Epivir) (lamivudine)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: HBV (Hepatitis B Virus), Hepatitis B | Phase 2 | Status: COMPLETED | Results posted: 2013-04-04